Digital PNG artwork · delivered by email | Secure checkout · no physical shipping
Hedi Raizer

Journal 6 min read

How Proteostasis Changes with Age

Proteostasis—the integrated network of protein synthesis, folding, trafficking, and degradation—undergoes measurable decline with age. This page summarizes research on the molecular mechanisms, tissue-specific vulnerabil

peptides-pro Editorial

How Proteostasis Changes with Age

Proteostasis, also called protein homeostasis, refers to the integrated cellular network that maintains the proteome: chaperone-assisted folding, quality control, trafficking, and degradation via the ubiquitin-proteasome system (UPS) and autophagy-lysosomal pathways. With age, this network loses efficiency, leading to the accumulation of damaged or misfolded proteins, impaired stress responses, and altered signaling. The decline is not uniform; it varies by tissue, cell type, and compartment, and is influenced by genetic, metabolic, and environmental factors.

Research on age-related proteostasis centers on several interconnected pathways, including the heat shock response (HSR), the unfolded protein response (UPR), the UPS, autophagy, mitochondrial quality control (mtQC), and NAD+-dependent signaling. The sections below summarize findings from recent studies, with explicit notation of the models used.

Research Studies

Astrocytic proteostasis in Parkinson's disease models

In a system-level model of Parkinson's disease (PD), pathological α-synuclein was reported to trigger a cycle of astrocytic failure that includes impaired proteostasis via the ubiquitin-proteasome and autophagy-lysosomal pathways [1]. The same review linked this failure to glymphatic collapse due to aquaporin-4 (AQP4) depolarization and to chronic neuroinflammation driven by microglial crosstalk and NLRP3 inflammasome activation [1]. These findings are drawn from a synthesis of cellular and animal studies; direct human validation remains limited.

Bone aging and multiscale proteostatic decline

A review of bone aging described the process as a multilevel degenerative phenomenon spanning molecular, cellular, tissue, and system levels [2]. At the molecular level, age-related changes include altered protein synthesis and degradation, accumulation of oxidized proteins, and impaired chaperone function. The review emphasized that bone aging is not merely bone mass loss but a networked decline that affects microstructure and biomechanical properties [2]. This work is largely based on animal models and human observational data.

NMNAT-1 and NAD+ homeostasis in neuroprotection

Nicotinamide mononucleotide adenylyltransferase 1 (NMNAT-1) catalyzes the final step in NAD+ biosynthesis and is the major nuclear isoform of the mammalian NMNAT family [4]. Age-associated NAD+ decline has been implicated in brain aging and neurodegenerative disorders, but the causal node and limiting compartment differ across tissues and disease states [4]. Direct human genetic evidence establishes NMNAT-1 as a causal gene in inherited axonal degeneration, linking NAD+ homeostasis to proteostatic stress responses [4].

CCT/TRiC chaperonin in therapy-induced senescence in glioblastoma

Glioblastoma multiforme (GBM) is described as chaperone dependent, relying on proteostasis networks for growth, invasion, and treatment resistance [5]. The eukaryotic chaperonin CCT/TRiC plays a central role in folding actin and tubulin and in maintaining proteostasis. Standard therapies drive many GBM cells into therapy-induced senescence (TIS), marked by permanent proliferation arrest, high metabolic activity, and the senescence-associated secretory phenotype (SASP) [5]. The persistence of senescent cells can fuel recurrence by altering the microenvironment and driving immunosuppression and stem-like traits [5]. This evidence comes from in vitro and animal models of GBM.

Mitochondrial quality control and senescence in mouse embryonic fibroblasts

Using mouse embryonic fibroblasts (MEFs) deficient in the mitochondrial protease HtrA2 (proteostasis), the transcription factor Chop (integrated stress response; ISR), or the mitophagy regulator Pink1, researchers investigated the interplay between mtQC pathways and cellular stress responses in DNA damage-induced senescence [6]. The study found that deficiencies in these pathways modulate senescence induction by genotoxic challenge, highlighting the contribution of mitochondria-nucleus communication to proteostatic stress and senescence [6]. This work is in vitro and animal-only.

Circadian regulation of proteostasis in Alzheimer's disease

A narrative review of circadian rhythms in Alzheimer's disease (AD) reported interactions between core clock genes and neurodegenerative cascades involving oxidative stress, neuroinflammation, glial reactivity, and proteostasis [7]. Disruptions in circadian-regulated molecular pathways, including BMAL1-SIRT1 and NF-κB-NLRP3, were suggested to contribute to AD pathogenesis and biomarker profiles [7]. The evidence is largely from animal models and human observational studies; direct causal evidence in humans is limited.

Plant cell proteostasis under salinity stress

In plants, salinity stress induces osmotic imbalance, ionic toxicity, and oxidative stress, leading to disruptions in photosynthesis, metabolism, and development [8]. Plants have evolved coordinated defense systems comprising structural and functional cellular protectors, including the cell wall, plasma membrane, vacuole, and peroxisome, which maintain cellular homeostasis under saline conditions [8]. This research is in plant models and provides a comparative perspective on proteostatic stress responses.

Nutritional paradox and anabolic resistance in uremia

In advanced chronic kidney disease (CKD), protein-energy wasting (PEW) drives morbidity and mortality [3]. A subset of uremic patients exhibits a "nutritional paradox" characterized by systemic anabolic resistance, rendering standard nutritional interventions often insufficient [3]. The proposed "sensitize-then-feed" framework suggests that molecular hierarchies driving this barrier must be addressed to improve outcomes [3]. This evidence is from human clinical observations and reviews.

Autophagy in hypothalamic neurons and obesity

In the arcuate nucleus, autophagy exerts divergent metabolic effects in the two principal appetite-regulating neuronal populations: POMC and AgRP neurons [9]. This reference-only finding indicates that impaired central endocrine regulation in obesity involves intertwined hypothalamic nutrient sensing, leptin responsiveness, and intracellular quality control [9]. The work is primarily in animal models.

Mitochondrial quality control in autoimmune diseases

New evidence highlights mitochondrial quality control as a determinant of cell type-specific metabolic vulnerability in heterogeneous autoimmune diseases (AIDs) [11]. This reference-only finding suggests that targeting mtQC may reprogram autoimmune immunity, but the evidence is early-stage and largely preclinical [11].

Environmental mycotoxins and Alzheimer's-relevant proteostasis

In SH-SY5Y cells, low-dose T-2 toxin (6 nM) for 24 h disrupted Alzheimer's-relevant App/Tau homeostasis via circadian-p53-senescence crosstalk [12]. This reference-only study reports that environmental mycotoxins can perturb AD-relevant proteostasis in human neuroblastoma cells, but the findings are in vitro and require further validation [12].

If you are reading this for personal health reasons

The compounds and pathways discussed here are sold for laboratory research only. We do not provide dosing, medical guidance, or recommendations for personal use. Anyone considering a compound for themselves should speak to a licensed clinician.

Sources

WhatsApp